These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 3731676)
1. Response to furosemide in chronic renal insufficiency: rationale for limited doses. Brater DC; Anderson SA; Brown-Cartwright D Clin Pharmacol Ther; 1986 Aug; 40(2):134-9. PubMed ID: 3731676 [TBL] [Abstract][Full Text] [Related]
2. Comparison of loop diuretics in patients with chronic renal insufficiency. Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953 [TBL] [Abstract][Full Text] [Related]
3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function. Traeger A; Stein G; Sperschneider H; Keil E Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency. Marone C; Reubi FC; Lahn W Eur J Clin Pharmacol; 1984; 26(4):413-8. PubMed ID: 6734705 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease. Sjöström P Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162 [TBL] [Abstract][Full Text] [Related]
7. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses]. Heuer LJ; Machnik H; Studt J; Fink R Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516 [TBL] [Abstract][Full Text] [Related]
8. [The kidney and diuretics]. Mampel E; Koall W; Luci V Z Gesamte Inn Med; 1980 Sep; 35(17):Suppl 66-9. PubMed ID: 7467586 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of furosemide in advanced renal failure. Huang CM; Atkinson AJ; Levin M; Levin NW; Quintanilla A Clin Pharmacol Ther; 1974 Oct; 16(4):659-66. PubMed ID: 4422027 [No Abstract] [Full Text] [Related]
16. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension. Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of high dose furosemide in patients with chronic renal failure or nephrotic syndrome. Kühnel HJ; Günther K; Stein G; Hoffmann-Traeger A Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):616-21. PubMed ID: 3429064 [TBL] [Abstract][Full Text] [Related]
18. [Diuretics and antihypertensive agents in chronic kidney insufficiency: comparison of the effects of metolazone and furosemide]. Groth H; Vetter H; Achermann R; Kuhlmann U; Siegenthaler W; Vetter W Schweiz Med Wochenschr; 1985 Jan; 115(2):41-5. PubMed ID: 3969541 [TBL] [Abstract][Full Text] [Related]
19. Elimination of furosemide in healthy subjects and in those with renal failure. Beermann B; Dalén E; Lindström B Clin Pharmacol Ther; 1977 Jul; 22(1):70-8. PubMed ID: 872498 [TBL] [Abstract][Full Text] [Related]
20. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis. Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]